HealthEquity Enters Material Definitive Agreement
Ticker: HQY · Form: 8-K · Filed: Nov 29, 2024 · CIK: 1428336
| Field | Detail |
|---|---|
| Company | Healthequity, INC. (HQY) |
| Form Type | 8-K |
| Filed Date | Nov 29, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $2.8 million, $30.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-action
Related Tickers: HQY
TL;DR
HealthEquity just signed a big deal, details TBD.
AI Summary
HealthEquity, Inc. announced on November 27, 2024, that it entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement, its terms, or any associated dollar amounts or parties involved.
Why It Matters
This filing indicates a significant business transaction for HealthEquity, Inc., the details of which will be crucial for investors to understand its potential impact on the company's future.
Risk Assessment
Risk Level: medium — The lack of specific details in this 8-K filing regarding the material definitive agreement introduces uncertainty and potential risk for investors.
Key Players & Entities
- HEALTHEQUITY, INC. (company) — Filer
- November 27, 2024 (date) — Date of Report
- 15 West Scenic Pointe Drive Suite 100 Draper , Utah 84020 (address) — Principal Executive Offices
FAQ
What is the nature of the Material Definitive Agreement entered into by HealthEquity, Inc.?
The filing states that HealthEquity, Inc. entered into a Material Definitive Agreement on November 27, 2024, but does not provide specific details about the agreement itself.
Who are the other parties involved in this Material Definitive Agreement?
The filing does not disclose the names of the other parties involved in the Material Definitive Agreement.
Are there any financial terms or dollar amounts associated with this agreement?
The filing does not specify any dollar amounts or financial terms related to the Material Definitive Agreement.
When was this Material Definitive Agreement officially entered into?
The Material Definitive Agreement was entered into on November 27, 2024.
What is the purpose of this 8-K filing?
This 8-K filing is to report the entry into a Material Definitive Agreement by HealthEquity, Inc.
Filing Stats: 536 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-11-29 13:02:04
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share HQY The NASDAQ Global Select
- $2.8 million — of the settlement, Union Mesa retained $2.8 million from a letter of credit that it previou
- $30.0 million — agreed to pay Union Mesa an additional $30.0 million. In exchange, the Company, WageWorks an
Filing Documents
- hqy-20241127.htm (8-K) — 23KB
- 0001428336-24-000106.txt ( ) — 147KB
- hqy-20241127.xsd (EX-101.SCH) — 2KB
- hqy-20241127_lab.xml (EX-101.LAB) — 22KB
- hqy-20241127_pre.xml (EX-101.PRE) — 13KB
- hqy-20241127_htm.xml (XML) — 3KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement On November 27, 2024, HealthEquity, Inc. (the "Company") and its wholly owned subsidiary WageWorks, Inc. agreed to settle their lawsuit with Union Mesa 1, LLC related to the termination of a lease in April 2021, which lawsuit was previously disclosed in the Company's periodic reports on Forms 10-K and 10-Q. Under the terms of the settlement, Union Mesa retained $2.8 million from a letter of credit that it previously received, and the Company and WageWorks jointly agreed to pay Union Mesa an additional $30.0 million. In exchange, the Company, WageWorks and Union Mesa each agreed to dismiss the lawsuit with prejudice and to release the other parties from all claims, as well as all past and future liability under the lease. The Company expects to record the settlement as a merger integration expense in the fiscal quarter ended October 31, 2024, with payment expected to be made during the fiscal quarter ending January 31, 2025.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (formatted in Inline XBRL) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHEQUITY, INC. Date: November 29, 2024 By: /s/ James Lucania Name: James Lucania Title: Executive Vice President and Chief Financial Officer